share_log

Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome

Benzinga Real-time News ·  Dec 6, 2021 08:11
Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment